UBS Upgrades IBM to Neutral with $236 Target After 13.2% Slide
UBS raised its rating on International Business Machines to Neutral from Sell and set a $236 price target after shares plunged 13.2% to $223.35. The downgrade revision follows Anthropic’s Claude Code AI announcement, which threatens to automate COBOL modernization and potentially erode IBM’s legacy mainframe services revenue.
1. UBS Revises Rating and Target
UBS upgraded IBM’s rating from Sell to Neutral and established a $236 price target, reflecting a more balanced outlook after recent volatility. The change follows a 13.2% one-day decline in IBM shares to $223.35, marking the stock’s worst single-session drop in years.
2. AI Tool Sparks Investor Concern
The share collapse was triggered by Anthropic’s introduction of Claude Code AI, which can analyze and modernize COBOL codebases. Investors worry the tool could reduce demand for IBM’s mainframe consulting and maintenance services, a key revenue stream.
3. Outlook for Mainframe and Services
IBM’s legacy mainframe business supports banking transactions, payment processing and government systems, and depends on specialized COBOL expertise. UBS believes the Neutral rating accounts for these threats while recognizing IBM’s hybrid cloud and AI consulting segments may offset potential mainframe headwinds.